Back to Search
Start Over
Additional file 11 of A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-��5 NAM (basmisanil) on intellectual disability associated with Down syndrome
- Publication Year :
- 2022
- Publisher :
- figshare, 2022.
-
Abstract
- Additional file 11. Co-morbid Symptoms: Change from Baseline at 6months. Table summarizing Conner���s, ADAMS and CSHQ data.
- Subjects :
- carbohydrates (lipids)
sense organs
skin and connective tissue diseases
Subjects
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....0c8df9c4862772f1e7d1417951601345
- Full Text :
- https://doi.org/10.6084/m9.figshare.19129010